
Conference Coverage
Latest Content

State Sanctions May Not Affect Medicaid Managed Care

FDA Approves Linerixibat for Cholestatic Pruritus in Primary Biliary Cholangitis

Biosimilar CT-P43 Matches Ustekinumab in Treating Moderate to Severe Plaque Psoriasis

Balancing Efficacy, Equity, and Shared Decision-Making in MS Care: Fred Lublin, MD

Menopausal Hormone Therapy Linked With Breast Cancer Risk Only When Progestin Is Involved

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

New research shows that cardiovascular protection from GLP-1 receptor agonists such as semaglutide and tirzepatide diminishes within months of discontinuation.

Factual tone, credible sources, and clinician representation increase trust and engagement, while humor may undermine vaccine messaging effectiveness.

Racial gaps in curative treatment for early-stage NSCLC persist among Medicare beneficiaries, with Black patients less likely to receive surgery.

Clonal hematopoiesis in chronic lymphocytic leukemia is widespread, shaping cytopenias, cardiovascular risk, and chemotoxicity.

Patients with multiple sclerosis valued both occupational therapy and physiotherapy as means of addressing their condition.

Study supports broader use of transient elastography to detect advanced liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease.

Icotrokinra is the first and only interleukin-23–targeted oral peptide approved for plaque psoriasis.


Smarter therapies, evolving frailty tools, and more inclusive trials are finally extending myeloma's survival gains to older adults.

A federal court blocked RFK Jr's vaccine agenda, freezing the ACIP shakeup and safeguarding child vaccine access as the legal fight over vaccines intensifies.







































